Cancer as a Data Problem: What AI Is Doing in Oncology
We track what has moved from promise to proximate execution, from AI-assisted candidate design with 2026 trial targets to agentic workflows that aim to handle multi-step oncology research tasks.
Cancer can be looked at as a data problem because a tumor is an evolving population of cells, each accumulating mutations, signaling to neighbors, evading immune surveillance, adapting to treatment. The challenge of modeling has historically outrun the tools available to do it, but computers have been catching up.
Read this Pro article free
Subscribe to BiopharmaTrend Insider, our free biweekly briefing on what matters in tech and bio, and get one free Pro article every month, starting with this one.
Insider arrives every two weeks, plus a short note when we publish a new deep dive. Unsubscribe anytime. Articles you unlock stay unlocked.
